Prognosis is variable and depends on many factors
including tumor location, histiologic grade and clinical stage.
Not exact matches
Clinical, histopathological, and molecular variables
included patient age, gender, extraocular extension,
tumor location (ciliary body or not), optic nerve invasion, angiotropism, neurotropism, melanoma cell type, BAP1 mutation, and monosomy 3.
Determining the optimal treatment plan takes a number of factors into consideration,
including the patient's preferences, the type, number,
location and aggressiveness of the
tumor (s) as well as the overall health of the patient.
Paris Descartes APHP and INSERM Poster # /
Location: 4546 / Section 25, Board 1 Hyperlink: http://www.abstractsonline.com/pp8/#!/4562/presentation/7648 The
tumor inflammation signature (TIS) and other gene expression signatures, simultaneously analyzed using the IO 360 panel, predict clinical benefit of anti-PD1 treatment (nivolumab and pembrolizumab) in «real life» patients with various cancer types,
including NSCLC.
The prognosis for cats with ISS varies depending on many factors,
including the size,
location, grade of the
tumor, and the treatment modalities chosen to treat it.
Depending on the
tumor location and the advanced nature of many cases, many drugs,
including L - aspariginase, Vincristine, Prednisone, Cyclophosphamide, and Doxorubricin may be used in sequence.
Clinical signs depend on the
location of the
tumor, but may
include seizures, behavior changes, compulsive circling, weakness, wobbliness, blindness and balance problems.
If your primary veterinarian suspects cancer, a referral to VSS may
include advanced diagnostic cancer testing —
including ultrasound, CT scans, and biopsy procedures — to identify the type,
location, and behavior of a
tumor.
Possible diagnostic tests will
include blood work, urinalysis, tissue biopsies or fine - needle aspirations, bone marrow aspirations, lymph node aspirations and possible X-rays, depending on the
location of the
tumor.
Prognostic factors
include location of the
tumor and size of the
tumor at surgical removal.
These
include: Potential migration of the chip into another
location Tumor development at the injection site (although this is extremely rare and no proven cases at this time) It is important to note that side effects have occurred in a very small portion of cats, and are considered very rare compared to the tens of millions of cats who have received microchips.
Prognosis of patients with this disease depends on multiple factors, the most commonly cited
including: presence of metastasis (negative), elevated alkaline phosphatase (negative), large
tumor size (negative), humerus
location (negative), treatment chosen (dogs receiving amputation and chemotherapy have improved survival times over dogs receiving amputation alone) 1.